Inhaled Corticosteroid Device Market Trends And Emerging Progress Challenges 2020-2027

This article was originally published on this site

The MarketWatch News Department was not involved in the creation of this content.

Jul 01, 2020 (Profound via COMTEX) — The global inhaler corticosteroid device market is expected to grow during the forecast period (2018 to 2023) at a CAGR of ~ 6.2 %.

Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices. Hence this factor is responsible for the growth of the inhaled corticosteroid device market.

Download Sample – https://www.novaoneadvisor.com/report/sample/2181

However, the high cost of treatment, misuse of funding and lack of awareness are some of the factors which are hampering the growth of the market during the forecast period.

Segmentation

The global inhaler corticosteroid device market is segmented into types of steroid inhalers, applications, and end-users. Based on types of steroid inhaler the market is segmented into beclomethasone dipropionate, budesonide, fluticasone inhaler powder, mometasone. On the basis of application, inhaler corticosteroid device market is segmented into asthma and COPD (chronic obstructive pulmonary disease), and other respiratory diseases. Based on end-user the market is segmented into hospitals, clinics, and respiratory care centers.

Key players

Some of the key players in the global inhaler corticosteroid device market are Plumage Therapeutics LLP, Pearl Therapeutic Inc, Teijin LTD, Glaxo’s Advair, LIYEN, Inc, Amgen Inc, Kos Pharmaceutical, Inc, and Teva Pharmaceutical.

Global Inhaler Corticosteroid Device Market, by Steroid Inhaler Types

  • Beclomethasone Dipropionate
  • Budesonide
  • Fluticasone Inhaler Powder
  • Mometasone

Global Inhaler Corticosteroid Device Market, by Application

  • Asthma
  • COPD (Chronic Obstructive Pulmonary Disease)
  • Others

Global Inhaler Corticosteroid Device Market, by End-User

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Respiratory Care Center

Download Full Report – https://www.novaoneadvisor.com/report/checkout/2181

PDF File Dispatch Time – 24 Hours. We Will also support Word, PPT, Excel Files Dispatch

Contact Us:

Nova One Advisor

URL – https://www.novaoneadvisor.com/

Mailing Address: 237 West 35th Street,Suite 605,New York, NY 10001, USA

Any Assistance, Email ndash; sales@novaoneadvisor.com

COMTEX_367568505/2630/2020-07-01T04:31:03

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.